Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Hires Baird to Assist with Strategy

NEW YORK (GenomeWeb News) – CombiMatrix today said that it has hired investment bank Robert W. Baird as a financial and strategic advisor to help the firm review "certain strategies aimed at unlocking shareholder value and creating synergistic relationships."

The Mukilteo, Wash.-based microarray and molecular diagnostics developer was expected to hire a firm to help it with such a review, after it announced a second-quarter revenue decline last month. At the time, CombiMatrix said that it expected to hire an advisor soon.

"CombiMatrix is at a major inflection point in its business plan, and we look forward to the advice provided by Baird in developing and evaluating certain corporate-level opportunities," CombiMatrix President and CEO Amit Kumar, said in a statement.

The firm said that it does not plan to provide updates on such opportunities until the review process is completed or terminated.

In early Wednesday trade on the Nasdaq, shares of CombiMatrix were unchanged at $6.99.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.